Key result
Shear wave elastography accurately identifies moderate-to-severe CKD with ~0.89 AUC for clinical rule-in.
Why the study?
Does shear wave elastography and an ultrasonic multi-parameter score accurately identify moderate-to-severe chronic kidney disease in patients with known CKD?
Cross-Sectional (n=152)
No
Does shear wave elastography and an ultrasonic multi-parameter score accurately identify moderate-to-severe chronic kidney disease in patients with known CKD?
Shear wave elastography cortical Young's modulus has high specificity for identifying moderate-to-severe CKD, making it potentially useful as a rule-in diagnostic tool.
OBJECTIVE: This study aimed to investigate the value of shear wave elastography (SWE) and an ultrasonic multi-parameter score in identifying chronic kidney disease (CKD) stage ≥ III (moderate-to-severe CKD) in patients with known CKD. METHODS: A single-centre cross-sectional study was conducted, enrolling 152 patients with CKD (staged I-V according to estimated glomerular filtration rate). Conventional ultrasound parameters (renal length, parenchymal thickness, echogenicity) and SWE measurements (Young's modulus [YM] in kPa) of the renal cortex and medulla were obtained. The ultrasonic multi-parameter score was calculated using a standardised rubric. Receiver operating characteristic curve analysis was performed to evaluate the diagnostic performance of SWE cortical YM and the multi-parameter score for identifying CKD stage ≥ III. RESULTS: The study included 23 patients with stage I CKD, 45 with stage II, 44 with stage III, 15 with stage IV and 25 with stage V. Shear wave elastography cortical YM (area under the curve [AUC]: 0.894) and the multi-parameter score (AUC: 0.870) showed promising discrimination for stage ≥ III CKD. Cortical YM demonstrated a specificity of 0.912 and a sensitivity of 0.671. CONCLUSION: Shear wave elastography cortical YM has high specificity, supporting its potential role in the rule-in of moderate-to-severe CKD. The ultrasonic multi-parameter score also shows clinical value for severity stratification. However, the relatively low sensitivity limits its utility for rule-out purposes. CLINICAL TRIAL NUMBER: Not applicable.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2026) conducted a cross-sectional in Chronic kidney disease (n=152). Shear wave elastography (SWE) cortical Young's modulus vs. Ultrasonic multi-parameter score was evaluated on Identification of CKD stage ≥III (moderate-to-severe CKD) (AUC 0.894, p=<0.05). Shear wave elastography cortical Young's modulus accurately identified moderate-to-severe chronic kidney disease with an AUC of 0.894, demonstrating high specificity for clinical rule-in.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: